News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mallinckrodt Pharmaceuticals (MNK) to Hold Investor Briefing in New York


11/8/2013 7:49:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DUBLIN--(BUSINESS WIRE)--Mallinckrodt (NYSE:MNK), a global specialty pharmaceutical and global medical imaging company, will hold an investor briefing on November 14, 2013. The meeting will be held at the Grand Hyatt at 109 East 42nd Street at Grand Central Terminal New York, NY from 8:30am to 9am Eastern Standard Time. Mark Trudeau, President and CEO of Mallinckrodt, along with members of Mallinckrodt’s senior management team, will present.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES